Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI Financing Cash Flow

Financing Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.09B+1,172%
Danaher logo
DanaherDHR
$46M+104%
Repligen logo
RepligenRGEN
-$5.54M-10.2%
ADMA Biologics logo
ADMA BiologicsADMA
-$10.13M-42.1%
Revvity logo
RevvityRVTY
-$88.9M+45.7%
TEC
Bio-TechneTECH
-$42.72M+37.2%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s financing cash flow?
Maravai LifeSciences Holdings, Inc. (MRVI) reported financing cash flow of -$55.23M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s financing cash flow changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s financing cash flow decreased by 1027.1% year-over-year, from -$4.9M to -$55.23M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s financing cash flow?
Over 3 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s financing cash flow has grown at a -53.0% compound annual growth rate (CAGR), from -$159.05M to -$16.5M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.